Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007

Transfusion

Volumn 49, Issue 10, 2009, Pages 2214-2220

  Amini Kafi Abad, Sedigheh ^a   Rezvan, Houri ^a   Abolghasemi, Hassan ^a   Talebian, Ali ^a  

^a IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ANALYSIS; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BLOODSTREAM INFECTION; CALCULATION; CHI SQUARE TEST; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IRAN; MALE; POPULATION; SAFETY; SCREENING; SYPHILIS;

BLOOD DONORS; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; IRAN; PREVALENCE;

EID: 70350450996     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02245.x     Document Type: Article

References (35)

1. Alter MJ. Epidemiology of hepatitis C infection. World J Gastroentrol 2007 13 : 2436 41.
2. CDC. The global HIV/AIDS pandemic, 2006. MMWR 2006 55 : 841 4.
3. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002 40 : 4068 71.
4. Zou S, Tepper M, El Saadany S. Prediction of hepatitis C burden in Canada. Can J Gastroenterol 2000 14 : 575 80.
5. Roy E, Haley N, Lecerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus infection among street youths. CMAJ 2001 165 : 557 60.
6. Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, Hoffman P, Hemmer R, Staub T, Seguin-Devaux C, Schmit JC. Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol 2008 14 : 11237 43.
7. Yee LJ, Weiss HL, Langner RG, Herrera J, Kaslow RA, van Leeuwen DJ. Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infect Dis 2001 1 : 8.
8. Murphy FL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR, Nemo GJ. Risk factors for hepatitis C infection in United States blood donors. NHLBI retrovirus epidemiology donor study (REDS). Hepatology 2000 31 : 756 62.
9. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks Sh, Hone D, O'Brien Sh, Sher G. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003 169 : 767 73.
10. Christensen PB, Groenbaek K, Krarup HB. Transfusion-acquired hepatitis C: the Danish look back experience. The Danish HCV [hepatitis C virus] Look back Group. Transfusion 1999 39 : 123 7.
11. González A, Esteban JI, Madoz P, Viladomiu L, Genesca J, Muñiz E, Enríquez J, Torras X, Hernández JM, Quer J. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial. Hepatology 1995 22 : 439 45.
12. Glynn SA, Kleinman SH, Schreiber GB, Bush MP, Wright DJ, Smith JW, Nass CC, Williams AE. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. JAMA 2000 284 : 229 35.
13. Offergeld R, Faensen D, Ritter S, Hamouda O. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill 2005 10 : 8 11.
14. Amini Kafi-abad S, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998 to 2007. Transfus Med 2009 in press.
15. Amini Kafi-abad S, Talebian A, Maghsoodlo M, Ramman S. Relative sensitivity of third generation hepatitis C virus antibody detection assay: evaluation of 20 kits [In Persian]. Khoon J 2005 2 : 171 81.
16. Massarat MS, Tahaghoghi-Mehrizad S. Iranian national health survey: a brief report. Arch Iranian Med 2002 5 : 73 9.
17. Soldan K, Barbara JA, Ramsay ME, Hall AJ. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang 2003 84 : 2740286.
18. Zou SH, Notari EP, Stramer SL, Wahab F, Musavi F, Dodd RY. Pattern of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 2004 44 : 1640 7.
19. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemol 2006 21 : 299 305.
20. Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol 2004 26 : 225 8.
21. Singh B, Verma M, Verma K. Markers for transfusion-associated hepatitis in North India blood donors: prevalence and trends. Jpn J Infect Dis 2004 57 : 49 51.
22. Second IR. Iran report about HIV and AIDS. 2007 In Persian P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007 13 : 3730 3.
23. Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trend of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. Jpn J Infect Dis 2007 60 : 389 91.
24. Likatavicius G, Hamers FF, Downs AM, Alix J, Nardone A. Trends in HIV prevalence in blood donations in Europe, 1990-2004. AIDS 2007 21 : 1011 8.
25. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in the world and Iran. J Iranian Med Council 1997 15 : 183 6.
26. Weekly epidemiological record. Relevé épidé miologique hebdomadaire. Geneva : World Health Organization. Available from URL: http://www.who.int/docstore/wer/pdf/2002/wer7706.pdf (accessed June 2008).
27. Jamali R, Khonsari M, Sh M, Khoshnia M, Jafari E, Kalhori AB, Abolghasemi H, Amini S, Maghsoudlu M, Deyhim MR, Rezvan H, Pourshams A. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol 2008 14 : 2867 71.
28. Alavian SM, Adibi P, Zali MR. Hepatitis C in Iran: epidemiology of emerging infection. Arch Iran Med 2005 8 : 84 90.
29. Ghadir MR, Jafari A, Amiriani MT, Rezvan H, Amini S, Pourshams A. Hepatitis C in Golestan province - Iran [In Persian]. Govaresh 2006 11 : 158 62.
30. Irani-Hakme N, Musharrafieh U, Samaha H, Almawi WY. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003. Am J Infect Control 2006 34 : 241 3.
31. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion-transmissible infections in North India voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang 1997 73 : 70 3.
32. Sarkodie F, Adarkwa M, Adu-Sarkodie Y, Candotti D, Acheampong JW, Allain JP. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang 2001 80 : 142 7.
33. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 2005 45 : 1973 80.
34. Soldan K, Davison K, Dow B. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill 2005 10 : 17 9.
35. Shang G, Seed CR, Wang F, Nie D, Farrugia A. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007 47 : 529 39.